27.9 C
Delhi
Thursday, June 19, 2025

WHO to drop HCQ from its global study into COVID-19 treatments: Dr Tedros

Date:

Share post:

Donate-GC-Razorpay

Geneva: The World Health Organisation (WHO) is to drop hydroxychloroquine from its global study into COVID-19 treatments. 

Speaking at the Global Media briefing today, Dr Tedros Adhanom Ghebreyesus, Director-General, WHO stated that in light of a paper published last week in The Lancet, that showed people taking hydroxychloroquine (HCQ) were at a higher risk of death and heart-related problems than those who were not taking HCQ. 

Dr Tedros revealed that the Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the data is reviewed by the Data Safety Monitoring Board

“The other arms of the trial are continuing. This concern relates to the use of hydroxychloroquine and chloraquine in #COVID19. I wish to reiterate that these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria,” Dr Tedros expressed.

Related articles

Modi Exposes Trump’s Fiction: India Needs No Mediator for Pakistan’s Terror Games

When a man known for bluster meets a leader who embodies resolve, truth is the first casualty in...

Sanskritik Yatra Sindhu Darshan Festival Organised in Kashmir

Under the banner of Shan-e-Shafaq, a cultural event, the ‘Sanskritik Yatra Sindhu Darshan Festival’ was organized at the...

Mangirish Salelkar returns as President of Goa Technology Association for 2025–2027

The Goa Technology Association (GTA), the state’s premier body representing IT, ITeS, BPO companies, and technology startups, has...

Predatory Sparrow Strikes: Cyber Justice Against Iran’s Bank of Terror

In a move that merges digital warfare with psychological reckoning, a cyber phantom has landed a decisive blow...